CONVIDIA clinical research

What CONVIDIA clinical research does

CONVIDIA clinical research GmbH is an independent, full-service Clinical Research Organization (CRO) headquartered in Münster, Westphalia, Germany, founded in 2012. The company plans, conducts, evaluates, and documents clinical trials and related studies for pharmaceutical companies, medical device manufacturers, and food supplement / phytopharmaceutical companies. Its service portfolio is organized around four pillars: Clinical Studies (Phase I–IV pharmaceutical trials, medical device performance evaluation under EU MDR, non-interventional studies (NIS), Investigator Initiated Trials (IITs), project management, and on-site/remote monitoring), Medical Writing (protocols, investigator brochures, ICH E3-compliant clinical study reports, ISO 14155/MDR clinical investigation reports, statistical evaluation, and CRF/eCRF design), Quality Management (SOP creation and system/site audits), and Pharmacovigilance (literature research, RMPs, DSURs, PSURs, MedDRA coding, and MDR-compliant medical device vigilance). Therapeutic area coverage spans 20+ indications including oncology, neurology, ophthalmology, ATMPs, digital health applications (DiGa), and orphan/rare diseases.

The underlying technology stack is built around a GCP-compliant eCRF/EDC electronic data capture system with real-time monitoring capabilities, MDR-compliant vigilance systems aligned to MDR Art. 87–92, and database programming for clinical data integration from multiple sources. All deliverables are produced in accordance with ICH-GCP, ISO 14155, EMA and FDA data standards, the EU Clinical Trial Regulation, and the German MPDG. The company describes its infrastructure as a qualified and established international partner network that extends delivery beyond the DACH region for cross-border sponsor studies.

Commercially, Convidia operates a direct, relationship-driven B2B sales model with no channel partners, marketplace listings, or self-serve channels. Revenue is generated through project-based professional services contracts negotiated directly with clients based on study scope, therapeutic area, phase, and geographic reach; no pricing is publicly disclosed. The firm is founder-led by Managing Director Dr. Stefan Siegmund, with a small, in-house interdisciplinary team (11–50 employees). Marketing is conducted through medical congress attendance, industry association memberships (EUCROF, CONELIS, Kooperation Phytopharmaka), and a bilingual corporate website; the company has no active social media presence, no recorded funding, and currently advertises no open positions.

Name

CONVIDIA clinical research

Legal name

CONVIDIA clinical research GmbH

Website

https://convidia.de

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

CONVIDIA clinical research GmbH is an independent, full-service Clinical Research Organization (CRO) in Münster, Germany, providing Phase I–IV trial management, medical device performance evaluation, medical writing, pharmacovigilance, and quality management services to pharmaceutical, medical device, and food supplement companies across the DACH region.

Ownership category

akta.pro rank

Product category

Clinical Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGAAAA

Clinical CROs (Phase I–IV)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAH

Pharmacovigilance, Risk Management & Medical Affairs CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAG

Medical Writing & Regulatory Submission Support CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAJAM

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

Keywords

• Clinical research services
• Clinical trial management
• Medical device vigilance
• Pharmacovigilance consulting
• Regulatory medical writing

Headquarters

HQ city

Muenster

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Contract Research Services (CRO): Convidia operates as a full-service Clinical Research Organization (CRO), providing comprehensive services for clinical trials including project management, monitoring, medical writing, statistical evaluation, quality management, and pharmacovigilance. Revenue is generated through service contracts with pharmaceutical companies, medical device manufacturers, and food supplement companies for the planning, conduct, evaluation, and documentation of clinical trials. Services span registration studies, NIS (Non-Interventional Studies), and Investigator Initiated Trials (IITs) across multiple therapeutic areas.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

CONVIDIA clinical research is a full-service Clinical Research Organization (CRO) that plans, conducts, evaluates, and documents clinical trials for pharmaceutical companies, medical device manufacturers, and food supplement/phytopharmaceutical firms. Services span Phase I–IV interventional trials, non-interventional studies (NIS), investigator-initiated trials (IITs), regulatory medical writing, statistical evaluation, eCRF/EDC data capture, project management, on-site and remote monitoring, pharmacovigilance (RMPs, DSURs, PSURs), medical device vigilance under MDR, SOP creation, and audit support.

Product overview

CONVIDIA clinical research is a full-service Clinical Research Organization (CRO) headquartered in Münster, Germany, offering an integrated suite of services for clinical trials. The portfolio is organized around four core pillars: Clinical Studies (covering Phase I–IV pharmaceutical trials, medical device testing, NIS, project management, and monitoring), Medical Writing (including regulatory document preparation, statistical evaluation, and CRF/eCRF design), Quality Management (SOP creation and audit services), and Pharmacovigilance (literature research, PSUR/DSUR, RMP, and medical device vigilance). These service modules are designed to be engaged individually or as a coordinated full-service package, supporting clients from study design through regulatory submission.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trials (Phase I–IV) Full-service management of Phase I through Phase IV interventional clinical trials for pharmaceutical sponsors, covering study design, ethics and authority submissions (CTIS, DMIDS), site selection and recruitment, on-site and remote monitoring, pharmacovigilance, statistical analysis, and final reporting.
• Clinical Testing of Medical Devices Performance evaluation and clinical investigation of medical devices in compliance with EU MDR, ISO 14155, and German MPDG, including preparation of clinical evidence for CE certification, coordination of biocompatibility testing, and ongoing post-market clinical follow-up.
• Non-Interventional Studies (NIS) Planning and supervision of non-interventional studies including observational studies, case-control studies, cohort studies, and registry studies, with registration support for statutory health insurance associations (BKV, GKV, PKV) in the German market.
• Project Management End-to-end clinical trial project management covering feasibility analysis, study design input, site selection and recruitment, regulatory authority submissions via CTIS and DMIDS, contract and payment management, and vendor coordination.
• Clinical Monitoring Clinical monitoring services including on-site and remote monitoring via eCRF, pre-trial site assessments, site initiation, interim monitoring, site close-out, and GCP/EU CTR-compliant documentation.
• Medical Writing Regulatory medical writing including study protocols, investigator brochures, informed consent forms, patient questionnaires and diaries, ICH E3-compliant clinical study reports, ISO 14155/MDR-compliant clinical investigation reports, and peer-reviewed publications and congress posters.
• Statistical Evaluation Statistical consulting, case number calculation, data management, statistical analysis, and interpretation in compliance with EMA and FDA data handling standards.
• Case Report Forms (CRF / eCRF) Design and programming of paper Case Report Forms and electronic Case Report Forms (eCRF/EDC) for patient data capture in clinical trials, including GCP-compliant interfaces and real-time monitoring capabilities.
• SOP Creation Development of practice-oriented Standard Operating Procedures (SOPs) for clinical trial operations, ensuring regulatory compliance while integrating with practical workflows.
• Audit Services External audit services including system audits, site audits, project-specific audits, and preparation support for regulatory inspections.
• Pharmacovigilance Services Comprehensive drug safety services including literature research, development of Risk Management Plans (RMPs), creation of Development Safety Update Reports (DSURs) during study phases and Periodic Safety Update Reports (PSURs) post-approval, and MedDRA/WHO-DD/WHO-ICD coding with license acquisition.
• Medical Device Vigilance Establishment of MDR-compliant vigilance systems for medical devices under MDR Art. 87-92, including eCRF-based reportable event capture, deadline monitoring, RMP development and updates, and regulatory reporting per national, European, and international requirements.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Kooperation PhytopharmakaminorStrategic or Co-development PartnerConvidia is a member of the Cooperation Phytopharmaceuticals (Kooperation Phytopharmaka), an industry association for phytopharmaceutical companies. Membership provides access to the phytopharmaceutical research community and supports Convidia's work with phytopharmaceutical and homeopathic remedy clients.
• Competence Network Lifescience (CONELIS)minorStrategic or Co-development PartnerConvidia is a supporting member (Fördermitglied) of the Competence Network Lifescience (CONELIS). This network connects companies and institutions in the lifesciences sector, providing a platform for knowledge exchange and collaboration within the German lifesciences ecosystem.
• EUCROF (European CRO Federation)coreStrategic or Co-development PartnerConvidia participates in the Innovative Medicine working group at EUCROF, the European CRO Federation. This is a core industry partnership that positions Convidia within the European clinical research community and provides access to collaborative initiatives, regulatory updates, and best practices across the European CRO landscape.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Medpace Holdings: Mid-size, full-service CRO focused on Phase I–IV trials across multiple therapeutic areas for small and mid-cap biotech sponsors. Highly comparable to Convidia in full-service delivery model and therapeutic-area breadth, with much greater scale.
• Worldwide Clinical Trials: Mid-size global CRO offering full-service Phase I–IV clinical research, biometrics, and pharmacovigilance for pharma and biotech sponsors. Comparable to Convidia in service breadth and mid-size positioning, but operates at materially larger scale and broader geographic footprint.
• TFS HealthScience: European-headquartered mid-size CRO providing full-service clinical development, biometrics, and pharmacovigilance across multiple therapeutic areas. Closely comparable to Convidia as a mid-size European CRO competing for similar pharma/biotech Phase II/III and post-marketing mandates.
• MLM Medical Labs: German-based central and specialty clinical trial laboratory services provider with strong DACH-region presence supporting pharma, biotech, and medical device trials. Comparable to Convidia on DACH-region clinical trial enablement, particularly for IVD, medical device, and pharmacovigilance-adjacent workflows.
• FGK Clinical Research: European (Munich-based) full-service CRO providing Phase I–IV clinical trial management, biometrics, regulatory affairs, and pharmacovigilance. The closest like-for-like competitor to Convidia in size, geography, and full-service DACH-focused boutique positioning.

Broad incumbents

• Parexel International: Global full-service CRO with Phase I–IV clinical operations, regulatory consulting, and biopharmaceutical services. Competes with Convidia for full-service pharma and medical device engagements, especially in Europe, but at a substantially larger enterprise scale.
• ICON plc: Global full-service CRO offering Phase I–IV clinical research, laboratory, and consulting services across all major therapeutic areas. Directly competes for Convidia's mid-size pharma/biotech Phase II/III and medical device study mandates at greater scale.
• IQVIA: World's largest CRO and life-science data/technology provider with comprehensive Phase I–IV, real-world evidence, and technology-enabled clinical operations. Competes with Convidia for Phase II–IV trials but at vastly greater scale, geographic reach, and technology intensity.
• Charles River Laboratories: Large global CRO/CDMO providing preclinical, clinical (Phase I–IV), and laboratory services across pharma, biotech, and medical device customers. Overlaps Convidia on Phase I–IV clinical execution and central lab services, but operates as a broad incumbent across the full drug-development value chain.

Regional players

• KKS Charité: Academic clinical trial coordination center (Koordinierungszentrum für Klinische Studien) at Charité Berlin supporting investigator-initiated trials and sponsored studies. Comparable to Convidia on German clinical trial execution and GCP-compliant operations, but driven by academic/sponsor relationships rather than commercial pharma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CONVIDIA clinical research